Bio-Rad Laboratories Inc
Closed
SectorHealthcare
366.65 -3.32
Overview
Share price change
24h
Min
351.01
Max
379.29
Income | -2.3M -13M |
|---|---|
Sales | 59M 651M |
P/E Sector Avg | 46.408 51.78 |
EPS | 2.62 |
Profit margin | -2.043 |
Employees | 7,450 |
EBITDA | 1.2B 542M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +15.79% upside |
Market Cap | 842M 9.8B |
|---|---|
Previous open | 369.97 |
Previous close | 366.65 |
Bio-Rad Laboratories Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Bio-Rad Laboratories Inc Forecast
Price Target
By TipRanks
15.79% upside
12 Months Forecast
Average 440 USD 15.79%
High 440 USD
Low 440 USD
Based on 1 Wall Street analysts offering 12 month price targets forBio-Rad Laboratories Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.